Today 2026.05.06 D-End
Today 
|
Satellite Symposium 3 Sep. 13 (Sat), 08:30-09:00 |
Room C (2F) |
|
|---|---|---|
| Chair(s) | Jae-Ho Yoon (College of Medicine, The Catholic University of Korea) | |
Role of IVIG in Stem Cell Transplantation and Immunotherapy in Hematologic Disease
Sungkyunkwan University School of Medicine, Korea
|
Satellite Symposium 4 Sep. 13 (Sat), 08:30-09:00 |
Room C (2F) |
|
|---|---|---|
| Chair(s) | Chul Won Jung (Sungkyunkwan University School of Medicine) | |
Role of Momelotinib in the Treatment of Myelofibrosis with Anemia
Chonnam National University Medical School, Korea
|
Joint Symposium 5 (ISCT-KSBMT) Sep. 13 (Sat), 09:00-10:30 |
Room A (1F) |
|
|---|---|---|
| Chair(s) |
Seok-Goo Cho (College of Medicine, The Catholic University of Korea) William Hwang (National Cancer Centre Singapore and Singapore General Hospital) |
|
Going Beyond Conventional CAR T Cell Therapies for Treatment of Blood Cancer and Other Diseases
National Cancer Centre Singapore and Singapore General Hospital, Singapore
Virus-Specific T-Cell Therapy: The Ultimate Weapon in the Endless Battle Against Post-Transplant Viral Infections
College of Medicine, The Catholic University of Korea, Korea
Mesenchymal Stroma Cells (MSC) in Autoimmune Diseases: Clinical Application in Systemic Sclerosis and in Systemic Lupus Erythematosus
AP-HP, Saint-Louis Hospital, France
|
Scientific Session 9 Sep. 13 (Sat), 09:00-10:30 |
Room C (2F) |
|
|---|---|---|
| Chair(s) |
June-Won Cheong (Yonsei University College of Medicine) Hyo Jung Kim (Hallym University College of Medicine) |
|
HokUS Scoring System for Predicting the Onset and Outcome of SOS
Hokkaido University Faculty of Medicine, Japan
Diagnosis and Management of Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
Cincinnati Children’s Hospital Medical Center, USA
Post-HSCT Viral Management: Strategies Beyond the Guidelines
College of Medicine, The Catholic University of Korea, Korea
|
Scientific Session 10 Sep. 13 (Sat), 09:00-10:30 |
Room D (2F) |
|
|---|---|---|
| Chair(s) |
Chul Won Jung (Sungkyunkwan University School of Medicine) Yoo Jin Kim (College of Medicine, The Catholic University of Korea) |
|
Evolving Paradigms in AML: How Transplantation Fits in the Modern Therapeutic Landscape
The University of Texas MD Anderson Cancer Center, USA
Immune Checkpoint Modulation in Myeloid Malignancies: Will We Find Success Soon?
Yale Cancer Center, USA
Augmenting NK-cell Immunity for the Treatment of Myeloid Malignancies using Hypomethylating Agents
Seoul National University College of Medicine, Korea
|
Joint Symposium 6 (TSBMT-KSBMT) Sep. 13 (Sat), 10:40-11:40 |
Room A (1F) |
|
|---|---|---|
| Chair(s) |
Jae-Ho Yoon (College of Medicine, The Catholic University of Korea) Hakan Goker (Hacettepe University Medical School) |
|
Pathophysiology and Management of Chronic GVHD
Hacettepe University Medical School, Türkiye
Neurologic Complications Following Hematopoietic Stem Cell Transplantation: Focus on Central Nervous System Graft-versus-Host Disease
University of Ulsan College of Medicine, Korea
|
Scientific Session 11 Sep. 13 (Sat), 10:40-12:10 |
Room C (2F) |
|
|---|---|---|
| Chair(s) |
Soo-Mee Bang (Seoul National University College of Medicine) Kihyun Kim (Sungkyunkwan University School of Medicine) |
|
Do We Need ASCT for MM Patients in the New Agent Era?
Lille University Hospital, France
Autologous NK Cell Therapy as a Consolidative Strategy after Auto-SCT
Karolinska Institutet, Sweden
The Role of Salvage Auto-HSCT in RRMM Patients
National Cancer Center, Korea
|
Nursing Session 2 Sep. 13 (Sat), 10:40-11:40 |
Room D (2F) |
|
|---|---|---|
| Chair(s) | Heejun Kim (Samsung Medical Center) | |
How Can We Reduce Liver-Related Morbidity and Mortality in Patients after HSCT?
College of Medicine, The Catholic University of Korea, Korea
Practical Oral Care for HSCT
Seoul National University College of Medicine, Korea
